Do Statins Benefit Low-Risk Type 2 Diabetes?

• by Kathryn Wighton

• January 5, 2026

NLR inflammasome pathways: key targets for pathogenesis and therapy of metabolic diseases

• by Jun Zhou, Ruohao Yang, Wanyu Zhu, Zhilin He, Yueke Ma, Zhiwei Feng, Lili Yu

• May 29, 2026

Frontiers and emerging trends in research on metabolic syndrome and metabolic dysfunction-associated fatty liver disease: a bibliometric analysis (2005-2024)

• by Weisong Zhang, Guangchen Liu, Xue Qu, Delong Cong, Yangyang Liu

• May 22, 2026

Ensitrelvir Reduced COVID After Household Exposure

In SCORPIO-PEP, symptomatic COVID-19 occurred in 3% vs 9% of household contacts by day 10.

• by Kathryn Wighton

• May 27, 2026

• 6 min